关于 ZURANOLONE
- 原研厂家
- Sage Therapeutics Inc.; Shionogi Pharmaceutical Co., Ltd.
- 适应症
- Postpartum Depression
- 获批日期
- 10/31/2023
- NCE 专利
- 10/31/2028
- DS/DP
- 04/17/2034
可供应中间体
当前列出 ZURANOLONE 的 6 个中间体。可就下方任一产品索取规格、文件或报价。
| 产品名称 | CAS 号 | 分子式 | 物理性质 |
|---|---|---|---|
| (5R,8R,9R,10S,13S,14S)-13-Methyldodecahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,4H)-dione | 5696-51-5 | / | / |
| (3R,5R,8R,9R,10S,13S,14S)-3-hydroxy-3,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one | 1632051-92-3 | / | / |
| 19-Norpregn-17(20)-en-3-ol, 3-methyl-, (3α,5β)- | 1430063-91-4 | / | / |
| (3R,5R,8R,9R,10S,13S,14S,17S)-17-(1-hydroxyethyl)-3,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-ol | 1430063-92-5 | / | / |
| 2-bromo-1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone | 1430063-93-6 | / | / |
| 1H-pyrazole-4-carbonitrile | 31108-57-3 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →